Redmile Group LLC 13D and 13G filings for Krystal Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 9:00 pm Sale | 2024-09-30 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 810,245 2.800% | -922,944 (-53.25%) | Filing |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,733,189 6.100% | -163,456 (-8.62%) | Filing |
| 2023-02-14 4:27 pm Purchase | 2022-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,896,645 7.400% | 75,747 (+4.16%) | Filing |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,820,898 7.300% | 145,862 (+8.71%) | Filing |
| 2021-02-16 4:08 pm Purchase | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,675,036 8.500% | 584,836 (+53.64%) | Filing |
| 2020-02-14 4:25 pm Purchase | 2019-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group LLC | 1,090,200 6.300% | 1,090,200 (New Position) | Filing |